EPHX2 and hypertensive disorder: Recently, sEH inhibitors were shown to be effective against neuropathic diabetic pain in rodent models [8], and against equine laminitis which is a complex and often fatal disease involving inflammation, hypertension, and severe neuropathic pain [9].